A Score of Non-Contrast Transthoracic Echocardiography to Detect Patent Foramen Ovale

Hui Zhang,Haiyan Tang,Fei Wu,Chun Yu,Qiang Dong,Wenjie Cao
DOI: https://doi.org/10.21203/rs.2.23613/v1
2020-01-01
Abstract:Background: The aim of this study was to develop a screening score of non-contrast transthoracic echocardiography (TTE) for patent foramen ovale (PFO) in patients with embolic stroke of undetermined source (ESUS). Methods: We performed a retrospective analysis of 218 consecutive patients with a recent ESUS from 2015 to 2018, who received TTE and transcranial Doppler (TCD) as routine examinations. PFO was diagnosed by the bubble test of TCD. Significant differences of the TTE findings between PFO group and non-PFO group were selected into a score. Results: PFO was diagnosed in 35.8% (78/218) of the patients. Compared with non-PFO group, a larger median aortic root diameter (ARd) (34mm vs. 32mm, p=0.005), a lower median peak E wave velocity (Em) (61.5cm/s vs. 68cm/s, p=0.005) and a lower incidence rate of mitral regurgitation (33.8% vs. 50.7%, p=0.016) were seen in PFO group. A three-point score of TTE criteria (including aortic root diameter>33mm, Em<72cm/s and without mitral regurgitation, AEM) was tested to be independently predict PFO (odd risk 1.95, 95%CI 1.37~2.78, p<0.001). AEM score ≥2 detected PFO with a sensitivity of 0.71 (95% CI 0.67~0.85) and a specificity of 0.53 (95% CI 0.44 - 0.55). Conclusion: The AEM score measured with non-contrast TTE can select ESUS patients for bubble test of TCD to detect PFO.
What problem does this paper attempt to address?